RAPH1 in cervical cancer proliferation, migration, and invasion: in vitro studies with SiHa and HeLa cells

Background: Ras association and pleckstrin homology domains 1 (RAPH1) may play a critical role in cervical cancer development, prompting us to investigate its potential role(s) in proliferation, migration, and invasion by cervical cancer cells. Materials and Methods: RAPH1 was knocked down in SiHa and HeLa cervical cancer cells using short interfering RNA. Effects of RAPH1 knock-down were assessed on cell proliferation using the CCK8 assay, and on cell migration and invasion using in vitro transwell assays. Results: Efficient RAPH1 knock-down significant reduced the proliferation, migration, and invasion abilities of SiHa and HeLa cells (p < 0.05). Conclusions: RAPH1 may promote tumor cell proliferation, migration, and invasion during cervical cancer development.

RAPH1; Cervical cancer; Cell migration

[1] Torre L.A., Bray F., Siegel R.L., Ferlay J., Lortet-Tieulent J., Jemal A.: “Global cancer statistics, 2012”. CA Cancer J. Clin., 2015, 65, 87.

[2] Chen W., Zheng R., Baade P.D., Zhang S., Zeng H., Bray F., et al.: “Cancer statistics in China, 2015”. CA Cancer J. Clin., 2016, 66, 115.

[3] Li J., Mei J., Wang X., Hu L., Lin Y., Yang P.: “Human papillomavirus type-specific prevalence in women with cervical intraepithelial neoplasm in western China”. J. Clin. Microbiol., 2012, 50, 1079.

[4] Krause M., Leslie J.D., Stewart M., Lafuente E.M., Valderrama F., Jagannathan R., et al.: “Lamellipodin, an Ena/VASP ligand, is implicated in the regulation of lamellipodial dynamics”. Dev Cell., 2004, 7, 571.

[5] Livak K.J., Schmittgen T.D.: “Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method”. Methods, 2001, 25, 402.

[6] Hansen S.D., Mullins R.D.: “Lamellipodin promotes actin assembly by clustering Ena/VASP proteins and tethering them to actin filaments”. Elife, 2015, 4. doi: 10.7554/eLife.06585.

[7] Wang J., King J.E., Goldrick M., Lowe M., Gertler F.B., Roberts I.S.: “Lamellipodin Is Important for Cell-to-Cell Spread and Actin-Based Motility in Listeria monocytogenes”. Infect. Immun., 2015, 83, 3740.

[8] Eppert K., Wunder J.S., Aneliunas V., Tsui L.C., Scherer S.W., Andrulis I.L.: “Altered expression and deletion of RMO1 in osteosarcoma”. Int. J. Cancer, 2005, 114, 738.

[9] Dahl E., Sadr-Nabavi A., Klopocki E., Betz B., Grube S., Kreutzfeld R., et al.: “Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer”. J. Pathol., 2005, 205, 21.

[10] Batistela M.S., Boberg D.R., Andrade F.A., Pecharki M., de S F Ribeiro E.M., Cavalli I.J., et al.: “Amplification and deletion of the RAPH1 gene in breast cancer patients”. Mol. Biol. Rep., 2013, 40, 6613.

[11] Gorai S., Paul D., Haloi N., Borah R., Santra M.K., Manna D.: “Mechanistic insights into the phosphatidylinositol binding properties of the pleckstrin homology domain of lamellipodin”. Mol. Biosyst., 2016, 12, 747.

[12] Lyulcheva E., Taylor E., Michael M., Vehlow A., Tan S., Fletcher A., et al.: “Drosophila pico and its mammalian ortholog lamellipodin activate serum response factor and promote cell proliferation”. Dev. Cell, 2008, 15, 680.

Chang Y.C., Zhang H., Brennan M.L., Wu J.: “Crystal structure of Lamellipodin implicates diverse functions in actin polymerization and Ras signaling”. Protein Cell., 2013, 4, 211.